Mohsen Pourazizi: Clinical Trials

5 trials sponsored by Mohsen Pourazizi, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 not yet recruiting, 1 unknown. 2 Phase 1, 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 12Not yet recruiting 1, Unknown 1
Phase 42Not yet recruiting 2
Phase 21Not yet recruiting 1
Phase 31Not yet recruiting 1

Follow Mohsen Pourazizi: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pupil Size and Choroidal Thickness Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Silodosin
Phase 4Not yet recruitingMohsen Pourazizi402026-08-012026-08-03
Iris Structural Changes With Tamsulosin vs. Silodosin in Benign Prostatic Hyperplasia Patients
tamsulosin 0.4mg, Silodosin 8 mg - Benign Prostatic Hyperplasia, Tamsulosin
Phase 4Not yet recruitingMohsen Pourazizi402026-08-012026-08-03
Efficacy and Safety of Oral Probiotics on Ocular Symptoms and Gut Microbiome of Children with Vernal Keratoconjunctivitis
Probiotic, Placebo Drug - Probiotic, Ocular Surface Disease
Phase 1Not yet recruitingMohsen Pourazizi322025-02-012025-01-27
Evaluating Efficacy and Safety of Oral Melatonin in Acute Central Serous Chorioretinopathy
melatonin 3mg, Placebo Drug - Central Serous Chorioretinopathy, Melatonin
Phase 2 / Phase 3Not yet recruitingMohsen Pourazizi482025-02-012025-02-05
Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024
Group 1 drug, Group 2: Drug and placebo, Group 3: Drug and palcebo - Ocular Surface Symptom, Ocular Surface Disease
Phase 1UnknownMohsen Pourazizi1502024-10-302024-10-03

Conditions studied

Iris Diseases (2)  ·  Prostatic Hyperplasia (2)  ·  Central Serous Chorioretinopathy (1)  ·  Conjunctivitis, Allergic (1)  ·  Endophthalmitis (1)  ·  Eye Pain (1)

Interventions

Tamsulosin (2)  ·  silodosin (2)  ·  Melatonin (1)  ·  Pharmaceutical Preparations (1)  ·  Probiotics (1)

Countries

Iran (1)